✦ LIBER ✦

Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme

✍ Scribed by Orloff, Mark S.; Turner, Anthony J.; Bunnett, Nigel W.

Book ID: 122973057
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 653 KB
Volume: 14
Category: Article
ISSN: 0167-0115
DOI: 10.1016/0167-0115(86)90202-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

POTENTIATION OF DEPRESSOR RESPONSES TO A

POTENTIATION OF DEPRESSOR RESPONSES TO ARACHIDONIC ACID BY ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE RAT

✍ S-C. G. Hui; S. Dai; C. W. Ogle 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

THE BLADDER ANGIOTENSIN SYSTEM IN FEMALE

THE BLADDER ANGIOTENSIN SYSTEM IN FEMALE RATS: PONSE TO INFUSIONS OF ANGIOTENSIN I AND THE ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRILAT

✍ WEAVER-OSTERHOLTZ, DANA; REAMS, GARRY; DE VERGEL, CRISTELA FARIA; BAUER, JOHN H. 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 54 KB

Is substance P released from slices of t

Is substance P released from slices of the rat spinal cord inactivated by peptidase(s) distinct from both ‘enkephalinase’ and ‘angiotensin-converting enzyme’?

✍ Mauborgne, A.; Bourgoin, S.; Benoliel, J.J.; Hamon, M.; Cesselin, F. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 450 KB

Metalloendopeptidase (EC 3.4.24.11) but

Metalloendopeptidase (EC 3.4.24.11) but not angiotensin converting enzyme is involved in the inactivation of substance P by synaptic membranes of the rat substantia nigra

✍ A. Oblin; M.J. Danse; B. Zivkovic 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Inhibitors of endopeptidase and angioten

Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model

✍ Song, Yafeng; Stål, Per S; Yu, Ji-Guo; Lorentzon, Ronny; Backman, Clas; Forsgren 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 777 KB

Angiotensin-Converting Enzyme Inhibitors

Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: Is There a Difference in Response and Any Advantage to Using Them Together in the Treatment of Hypertension?

✍ Marvin Moser; Clive Rosendorff; William B. White 📂 Article 📅 2008 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 606 KB